Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 52 (1) , 27-30
- https://doi.org/10.1016/s0015-0282(16)60783-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Histologic study of ovarian endometriosis after hormonal therapyFertility and Sterility, 1988
- Combined (hormonal and microsurgical) therapy in infertile women with endometriosisFertility and Sterility, 1987
- LHRH ANALOGUES AND BONE LOSSThe Lancet, 1987
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)Fertility and Sterility, 1985
- Treatment of endometriosis with danazol: report of a 6-year prospective studyFertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.Journal of Clinical Endocrinology & Metabolism, 1982
- Classification of EndometriosisFertility and Sterility, 1979